Literature DB >> 24740565

MicroRNA-195 regulates steroid receptor coactivator-3 protein expression in hepatocellular carcinoma cells.

Hong-Lei Jiang1, Hao Yu, Xu Ma, Dong Xu, Guo-Fu Lin, Dong-Yan Ma, Jun-Zhe Jin.   

Abstract

Multiple studies have shown that steroid receptor coactivator-3 (SRC-3) is upregulated and promotes cell proliferation in several human cancers, including breast, lung, and prostate carcinoma. However, its molecular determinants remain largely unexplored. In the current study, by way of informatics software, we found that MicroRNA-195 (miR-195) could negatively regulate protein levels of SRC-3 through targeting its 3'-untranslated region (3'-UTR) in hepatocellular carcinoma (HCC) cells. As a result, miR-195 mimics inhibited while its antisense enhanced SRC-3 protein levels. Furthermore, miR-195 could modulate cell proliferation and tumor growth in vivo and in vitro. Therefore, our results demonstrate a novel molecular mechanism for the dysregulated expression of SRC-3 in hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24740565     DOI: 10.1007/s13277-014-1933-x

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  20 in total

1.  The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development.

Authors:  J Xu; L Liao; G Ning; H Yoshida-Komiya; C Deng; B W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  Stimulation of steroid receptor coactivator-3 (SRC-3) gene overexpression by a positive regulatory loop of E2F1 and SRC-3.

Authors:  Paola Mussi; Chundong Yu; Bert W O'Malley; Jianming Xu
Journal:  Mol Endocrinol       Date:  2006-08-17

3.  ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion.

Authors:  Weiwen Long; Charles E Foulds; Jun Qin; Jian Liu; Chen Ding; David M Lonard; Luisa M Solis; Ignacio I Wistuba; Jun Qin; Sophia Y Tsai; Ming-Jer Tsai; Bert W O'Malley
Journal:  J Clin Invest       Date:  2012-04-16       Impact factor: 14.808

Review 4.  Steroid receptor coactivator (SRC) family: masters of systems biology.

Authors:  Brian York; Bert W O'Malley
Journal:  J Biol Chem       Date:  2010-10-18       Impact factor: 5.157

5.  The genetic ablation of SRC-3 protects against obesity and improves insulin sensitivity by reducing the acetylation of PGC-1{alpha}.

Authors:  Agnès Coste; Jean-Francois Louet; Marie Lagouge; Carles Lerin; Maria Cristina Antal; Hamid Meziane; Kristina Schoonjans; Pere Puigserver; Bert W O'Malley; Johan Auwerx
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-28       Impact factor: 11.205

6.  MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells.

Authors:  Teng Xu; Ying Zhu; Yujuan Xiong; Yi-Yuan Ge; Jing-Ping Yun; Shi-Mei Zhuang
Journal:  Hepatology       Date:  2009-07       Impact factor: 17.425

Review 7.  Steroid receptor coactivator-3 as a potential molecular target for cancer therapy.

Authors:  Jean Ching-Yi Tien; Jianming Xu
Journal:  Expert Opin Ther Targets       Date:  2012-08-27       Impact factor: 6.902

8.  Atypical regulation of SRC-3.

Authors:  Michael J Garabedian; Susan K Logan
Journal:  Trends Biochem Sci       Date:  2008-05-24       Impact factor: 13.807

Review 9.  Molecular structure and biological function of the cancer-amplified nuclear receptor coactivator SRC-3/AIB1.

Authors:  Lan Liao; Shao-Qing Kuang; Yuhui Yuan; Sonia M Gonzalez; Bert W O'Malley; Jianming Xu
Journal:  J Steroid Biochem Mol Biol       Date:  2002-12       Impact factor: 4.292

Review 10.  SRC-3 has a role in cancer other than as a nuclear receptor coactivator.

Authors:  Gang Ma; Yu Ren; Ke Wang; Jianjun He
Journal:  Int J Biol Sci       Date:  2011-05-24       Impact factor: 6.580

View more
  11 in total

1.  microRNA-195-Cdc42 axis acts as a prognostic factor of esophageal squamous cell carcinoma.

Authors:  Niuniu Sun; Lin Ye; Tingmin Chang; Xiaojing Li; Xiumin Li
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

2.  miR-137 inhibits the proliferation of human non-small cell lung cancer cells by targeting SRC3.

Authors:  Ruilin Chen; Yongqing Zhang; Chengcheng Zhang; Hua Wu; Shumei Yang
Journal:  Oncol Lett       Date:  2017-03-24       Impact factor: 2.967

3.  MiR-141 targets ZEB2 to suppress HCC progression.

Authors:  Shi-Min Wu; Hong-Wu Ai; Ding-Yu Zhang; Xiao-Qun Han; Qin Pan; Feng-Ling Luo; Xiao-Lian Zhang
Journal:  Tumour Biol       Date:  2014-07-10

Review 4.  Roles for miRNAs in endocrine resistance in breast cancer.

Authors:  Penn Muluhngwi; Carolyn M Klinge
Journal:  Endocr Relat Cancer       Date:  2015-10       Impact factor: 5.678

5.  miR-141 suppresses the growth and metastasis of HCC cells by targeting E2F3.

Authors:  Jun Xue; Yan-Feng Niu; Jing Huang; Gang Peng; Li-Xia Wang; Yu-Hui Yang; Yun-Qiao Li
Journal:  Tumour Biol       Date:  2014-08-21

Review 6.  miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets.

Authors:  Carolyn M Klinge
Journal:  Mol Cell Endocrinol       Date:  2015-02-03       Impact factor: 4.102

7.  A meta-analysis of microRNA expression in liver cancer.

Authors:  Jingcheng Yang; Shuai Han; Wenwen Huang; Ting Chen; Yang Liu; Shangling Pan; Shikang Li
Journal:  PLoS One       Date:  2014-12-09       Impact factor: 3.240

8.  miR-195 in human primary mesenchymal stromal/stem cells regulates proliferation, osteogenesis and paracrine effect on angiogenesis.

Authors:  Maria Ines Almeida; Andreia Machado Silva; Daniel Marques Vasconcelos; Catarina Rodrigues Almeida; Hugo Caires; Marta Teixeira Pinto; George Adrian Calin; Susana Gomes Santos; Mário Adolfo Barbosa
Journal:  Oncotarget       Date:  2016-01-05

9.  The miR-29 transcriptome in endocrine-sensitive and resistant breast cancer cells.

Authors:  Penn Muluhngwi; Negin Alizadeh-Rad; Stephany L Vittitow; Ted S Kalbfleisch; Carolyn M Klinge
Journal:  Sci Rep       Date:  2017-07-12       Impact factor: 4.379

10.  miR-195 inhibits cell proliferation via targeting AEG-1 in hepatocellular carcinoma.

Authors:  Jing-Jun Yan; Ying Chang; Yu-Nan Zhang; Ju-Sheng Lin; Xing-Xing He; Huan-Jun Huang
Journal:  Oncol Lett       Date:  2017-03-08       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.